换一批
换一批A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib.
作者：
Yongfeng,Yu [1]
;
Wen,Dong [2]
;
Yanxia,Shi [3]
;
Rong,Wu [4]
;
Qitao,Yu [5]
;
Feng,Ye [6]
;
Chengzhi,Zhou [7]
;
Xiaorong,Dong [8]
;
Xingya,Li [9]
;
Yongsheng,Li [10]
;
Zhen,Li [11]
;
Lin,Wu [12]
;
Yueyin,Pan [13]
;
Hong,Shen [14]
;
Dehua,Wu [15]
;
Zhongyuan,Xu [16]
;
Jinsheng,Wu [17]
;
Nong,Xu [18]
;
Yanru,Qin [19]
;
Aimin,Zang [20]
;
Jingdong,Zhang [21]
;
Jianya,Zhou [22]
;
Xiaotao,Zhang [23]
;
Yanqiu,Zhao [24]
;
Fugen,Li [25]
;
Huizhen,Wang [25]
;
Qi,Liu [25]
;
Zhenyong,Han [25]
;
Jin,Li [26]
;
Shun,Lu [27]
作者单位：
Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
[1]
Department of Respiratory Medicine, Hainan Cancer Hospital, Haikou, China.
[2]
Internal Medicine Department, Sun Yat-Sen University Cancer Center, Guangzhou, China.
[3]
Second Medical Oncology Breast Tumors, Shengjing Hospital of China Medical University, Shenyang, China.
[4]
Department of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, China.
[5]
Department of Medical Oncology, The First Affiliated Hospital of Xiamen University, Fujian, China.
[6]
Department of Oncology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
[7]
Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
[8]
Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
[9]
Internal Medicine-Oncology and Phase I Clinical Trial Center, Chongqing University Cancer Hospital, Chongqing, China.
[10]
Internal Medicine 5, Linyi Cancer Hospital, Linyi, China.
[11]
Second Department of Thoracic Medicine, Hunan Cancer Hospital, Changsha, China.
[12]
Department of Oncology and Chemotherapy, Anhui Provincial Hospital, Hefei, China.
[13]
Department of Medical Oncology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
[14]
Radiotherapy Department, Nanfang Hospital, Southern Medical University, Guangzhou, China.
[15]
Nanfang Hospital National Drug Clinical Trial Institution, Nanfang Hospital, Southern Medical University, Guangzhou, China.
[16]
Department of Radiotherapy, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
[17]
Internal Medicine-Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
[18]
Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University of Medicine, Zhengzhou, China.
[19]
Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China.
[20]
Gastroenterology Department, Liaoning Cancer Hospital and Institute, Shenyang, China.
[21]
Department of Respiratory Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
[22]
Radiotherapy Department, The Affiliated Qingdao Central Hospital of Qingdao University, Qingdao, China.
[23]
Department of Medical Oncology, Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
[24]
Haihe Biopharma Co., Ltd, Shanghai, China.
[25]
Department of Medical Oncology, Shanghai East Hospital, Tongji University, 150 Jimo Road, Pudong New Area, Shanghai 200123, China.
[26]
Department of Medical Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, No. 241 Huaihai West Road, Shanghai 200030, China.
[27]
DOI
10.1177/17588359241264730
PMID
39091606
发布时间
2024-08-03
- 浏览0
Therapeutic advances in medical oncology
17588359241264730页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
